No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly females |
293373 |
2. Check conditionsNone |
293373 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
104 |
4. Check minimum number of eventsNone |
104 |
5. Include endpointsNone |
104 |
6. Filter based on genotype QC (FinnGen only) |
104 |
Control definitions (FinnGen only)
- Control exclude
- N14_FEMALEGENNONINF
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- N83
- Name in latin
- Atrophia acquisita ovarii et tubae uterinae
Similar endpoints
↥List of similar endpoints to
Acquired atrophy of ovary and fallopian tube
based on the number of shared cases.
Similar with more cases:
- Noninflammatory disorders of female genital tract
- Genitourinary diseases
- Any operation in hilmo
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 567 | 567 | - |
| Only index persons | 554 | 554 | - |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.02 | 0.02 | - |
| Only index persons | 0.02 | 0.02 | - |
| Median age at first event (years) | |||
| Whole population | - | 41.06 | - |
| Only index persons | - | 40.51 | - |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 104 | 104 | - |
| Unadjusted period prevalence (%) | 0.04 | 0.04 | - |
| Median age at first event (years) | 41.20 | 41.20 | - |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 90
- Matched controls
- 900
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
N83.3
ICD-10 Finland
Acquired atrophy of ovary and fallopian tube
+∞
129.6
90
*
N83.2
ICD-10 Finland
Other and unspecified ovarian cysts
100.8
38.2
40
7
N80.3
ICD-10 Finland
Endometriosis of pelvic peritoneum
+∞
24.0
22
*
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
10.0
21.9
57
132
N80.1
ICD-10 Finland
Endometriosis of ovary
+∞
18.3
17
*
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
17.7
14.7
23
17
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
6.4
13.4
42
108
N92.1
ICD-10 Finland
Excessive and frequent menstruation with irregular cycle
81.8
13.0
14
*
JAL21
NOMESCO Finland
Laparoscopic excision or destruction of lesion of peritoneum
+∞
11.7
11
*
N80.9
ICD-10 Finland
Endometriosis, unspecified
+∞
11.7
11
*
N92.0
ICD-10 Finland
Excessive and frequent menstruation with regular cycle
32.7
11.1
14
5
N84.0
ICD-10 Finland
Polyp of corpus uteri
123.8
10.7
11
*
N97.9
ICD-10 Finland
Female infertility, unspecified
+∞
10.6
10
*
LCA06
NOMESCO Finland
Biopsy of endometrium
10.6
9.9
19
22
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
4.3
9.8
50
201
N80.0
ICD-10 Finland
Endometriosis of uterus
111.2
9.6
10
*
LAC01
NOMESCO Finland
Laparoscopic excision of ovarian cyst
+∞
9.5
9
*
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
8.3
9.0
20
30
N95.0
ICD-10 Finland
Postmenopausal bleeding
30.9
8.7
11
*
JAH01
NOMESCO Finland
Laparoscopy
12.4
7.6
13
12
SPAT1254
SPAT
Administration of medicine
5.7
7.6
22
48
N83.0
ICD-10 Finland
Follicular cyst of ovary
87.0
7.5
8
*
N95.1
ICD-10 Finland
Menopausal and female climacteric states
+∞
7.4
7
*
N83.8
ICD-10 Finland
Other noninflammatory disorders of ovary, fallopian tube and broad ligament
+∞
7.4
7
*
N83.1
ICD-10 Finland
Corpus luteum cyst
+∞
7.4
7
*
LC2AE
NOMESCO Finland
Ultrasound examination of uterus and parametria
6.4
7.3
19
36
J02AC01
ATC
fluconazole; systemic
3.4
7.2
60
331
UJF32
NOMESCO Finland
Coloscopy
3.8
7.0
35
128
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.7
6.6
34
128
ULC02
NOMESCO Finland
Hysteroscopy
15.8
6.6
10
7
LAF01
NOMESCO Finland
Laparoscopic unilateral salpingo-oophorectomy
74.9
6.5
7
*
L02AE02
ATC
leuprorelin; implant, parenteral
28.9
6.3
8
*
LBF01
NOMESCO Finland
Laparoscopic perfusion of Fallopian tube
+∞
6.3
6
*
N80.5
ICD-10 Finland
Endometriosis of intestine
+∞
6.3
6
*
LCB25
NOMESCO Finland
Hysteroscopic excision of lesion
+∞
6.3
6
*
N81.2
ICD-10 Finland
Incomplete uterovaginal prolapse
+∞
6.3
6
*
N73.6
ICD-10 Finland
Female pelvic peritoneal adhesions
+∞
6.3
6
*
LAF11
NOMESCO Finland
Laparoscopic bilateral salpingo-oophorectomy
11.2
6.2
11
11
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
59
367
2.40
4.59
7.2
4.2
0.0
0.0
estimate
—
9
68
59
372
2.35
4.38
5.3
3.1
0.0
0.0
estimate
—
10
68
84
624
2.80
4.29
4.4
3.9
9.1
10.4
mm/h
0.62
79
580
58
373
2.25
4.00
5.2
3.0
0.0
0.0
estimate
—
8
72
46
281
2.14
3.48
5.5
3.2
—
—
—
0
0
8
16
5.32
3.12
2.0
1.3
53.4
93.3
pmol/l
—
8
16
54
362
2.02
3.10
4.5
3.4
—
—
—
0
0
59
409
2.02
3.07
5.9
5.9
9.3
9.5
umol/l
0.09
59
393
21
98
2.43
2.96
2.0
1.8
—
—
—
0
0
13
48
2.95
2.84
1.3
1.6
—
—
—
0
0
85
692
2.25
2.65
4.9
4.0
14.8
14.4
pmol/l
0.77
79
644
95
829
2.69
2.58
5.6
4.6
1.6
1.9
mu/l
2.12
88
774
52
363
1.87
2.49
6.5
5.7
1.2
1.2
mmol/l
0.20
44
314
27
154
2.02
2.33
1.4
1.2
3.7
10.4
u/ml
0.71
12
58
10
37
2.88
2.17
1.6
1.5
—
—
—
0
0
97
869
2.73
2.17
18.0
10.6
18.3
20.7
mg/l
0.31
77
633
13
57
2.46
2.07
2.5
3.2
6.2
5.9
kpa
0.41
13
57
31
195
1.84
1.99
1.5
1.3
—
—
—
0
0
27
165
1.86
1.89
1.4
1.2
7.3
16.8
iu/ml
—
10
50
14
68
2.22
1.80
1.9
1.6
—
—
—
0
0
38
262
1.71
1.77
3.5
3.4
72.0
19.7
ng/l
0.40
18
164
14
69
2.19
1.74
2.3
1.7
—
—
—
0
0
92
813
2.14
1.71
4.3
3.9
5.9
5.8
mmol/l
0.20
83
757
28
180
1.76
1.66
2.3
1.9
—
—
—
0
0
40
286
1.65
1.61
2.3
1.9
94.4
94.2
pmol/l
0.01
16
136
8
33
2.54
1.57
1.4
1.5
—
—
—
0
0
5
15
3.45
1.54
1.6
1.5
—
—
—
0
0
5
15
3.45
1.54
1.4
1.4
—
—
—
0
0
5
15
3.45
1.54
1.6
1.6
—
—
—
0
0
7
28
2.61
1.48
3.1
2.3
58.9
43.5
%
—
7
28
7
28
2.61
1.48
2.0
2.0
—
—
—
0
0
13
67
2.07
1.46
1.2
1.7
—
—
—
0
0
17
97
1.90
1.45
1.5
2.0
—
—
—
0
0
5
16
3.23
1.45
1.4
2.0
—
—
—
0
0
5
16
3.23
1.45
1.8
1.2
—
—
—
0
0
5
16
3.23
1.45
1.8
1.2
—
—
—
0
0
30
204
1.66
1.44
6.4
3.4
0.0
0.0
estimate
—
10
70
70
584
1.61
1.43
3.9
2.7
33.3
36.1
u/l
0.29
70
558
0
37
0.00
1.37
0.0
1.5
—
—
—
0
0
94
853
2.06
1.36
4.3
3.9
5.0
4.9
mmol/l
0.19
87
795
27
183
1.64
1.31
2.0
1.8
1.6
0.9
mg/l
1.00
18
136
5
18
2.86
1.30
1.6
1.7
—
—
—
0
0
86
764
1.73
1.28
5.1
4.6
38.2
38.7
mmol/mol
0.20
78
722
8
36
2.32
1.27
1.3
1.3
—
—
—
0
0
14
79
1.89
1.24
2.3
5.7
1.0
1.0
mmol/l
0.20
14
74
18
112
1.73
1.18
1.6
2.2
—
—
—
0
0
0
35
0.00
1.17
0.0
1.4
—
—
—
0
0
0
35
0.00
1.17
0.0
1.4
—
—
—
0
0
0
35
0.00
1.17
0.0
1.4
—
—
—
0
0
5
20
2.57
1.16
1.0
1.2
—
—
—
0
0
5
20
2.57
1.16
1.6
1.7
—
—
—
0
0
93
851
1.88
1.15
4.2
3.8
1.6
1.6
mmol/l
0.05
85
794
90
816
1.76
1.15
3.8
3.5
1.3
1.2
mmol/l
0.51
82
757
13
74
1.86
1.13
2.5
3.3
—
—
—
0
0
7
32
2.27
1.10
13.6
5.9
26.6
25.8
mmol/l
—
7
32
7
32
2.27
1.10
3.1
1.9
1.7
1.2
%
—
7
32
94
867
1.88
1.07
4.7
4.3
3.0
2.9
mmol/l
0.05
86
809
5
22
2.33
1.04
1.4
2.1
—
—
—
0
0
5
22
2.33
1.04
1.2
1.2
—
—
—
0
0
5
22
2.33
1.04
2.0
3.4
3.9
3.7
g/l
—
5
22
10
54
1.94
1.00
1.2
1.6
—
—
—
0
0
28
205
1.50
0.97
1.3
1.2
0.5
1.8
u/ml
—
7
52
88
811
1.55
0.83
14.4
9.9
85.6
84.8
ml/min/173m2
0.16
73
648
10
58
1.80
0.83
10.6
6.3
119.2
119.9
g/l
—
10
58
71
631
1.39
0.80
3.5
3.3
—
—
—
0
0
9
54
1.73
0.77
1.4
1.5
—
—
—
0
0
5
24
2.14
0.75
1.4
2.0
—
—
—
0
0
7
38
1.90
0.75
15.6
6.7
2.0
1.2
%
—
7
38
11
68
1.69
0.75
2.5
2.7
4.4
4.7
pmol/l
0.48
11
63
5
26
1.97
0.71
1.4
1.6
169.0
297.1
mu/l
—
5
20
7
42
1.71
0.70
4.7
5.2
25.3
25.0
mmol/l
—
7
42
16
117
1.43
0.56
3.3
2.4
0.2
1.1
e6/l
—
10
61
7
49
1.46
0.47
2.1
3.8
1.2
1.2
mmol/l
—
7
42
5
33
1.54
0.42
1.8
1.6
—
—
—
0
0
14
109
1.33
0.36
3.4
2.5
3.3
3.8
e6/l
—
8
52
23
194
1.24
0.33
1.4
1.6
—
—
—
0
0
16
133
1.24
0.26
4.5
2.2
2.5
2.4
mmol/l
0.79
16
117
11
87
1.30
0.25
12.0
6.1
—
—
—
0
0
11
88
1.28
0.23
1.9
1.5
1.4
1.3
%
0.50
11
73
13
107
1.25
0.23
1.6
2.4
13.4
13.9
umol/l
0.07
13
101
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
14
0.00
0.20
0.0
2.2
—
—
—
0
0
5
59
0.84
0.00
1.0
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.2
—
13.6
—
0
5
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
72
0.97
0.00
2.1
2.0
24.1
56.6
u/l
—
7
65
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
3.2
—
—
—
0
0
0
5
0.00
0.00
0.0
2.2
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
1.9
—
0
6
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
3.5
—
1177.0
—
0
6
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint N14_ATROPHOV and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have N14_ATROPHOV.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: N14_ATROPHOV – Acquired atrophy of ovary and fallopian tube
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data